Ultrasound Responsive Nanobubble Compositions and Methods of Production and Use Thereof
AssigneeUniversity of Central Florida Research Foundation, lnc.
InventorsAngela SHAR, Mehdi RAZAVI
Life of this patent
Estimating the term…
Abstract
Compositions, methods, and kits relating to ultrasound targeted nanobubble compositions are disclosed. The nanobubble compositions comprise a hollow core containing at least one gas; at least one therapeutic agent disposed in the hollow core; a polymer shell encircling the hollow core; and at least one targeting agent incorporated in the polymer shell. Methods of producing and using the nanobubble compositions are also disclosed.
Claims36
An ultrasound responsive targeted nanobubble composition, comprising:
- a hollow core containing at least one gas;
- a polymer shell encircling the hollow core;
- at least one therapeutic agent disposed in the hollow core and/or encapsulated within the polymer shell;
- and
- at least one targeting agent incorporated in the polymer shell and/or attached to a surface of the polymer shell, wherein the at least one targeting agent targets the nanobubble composition to at least a portion of a musculoskeletal system of a patient.
A method of preparing an ultrasound responsive targeted nanobubble composition, the method comprising the steps of:
- (1) mixing at least one therapeutic agent with at least one gas and at least one polymer to form a first mixture;
- (2) sonicating the first mixture to form nanobubbles that comprise a polymer shell formed about a hollow core containing the at least one therapeutic agent and the at least one gas;
- (3) isolating the nanobubbles;
- and
- (4) contacting the nanobubbles with at least one targeting agent to form a second mixture and incubating the second mixture under conditions that allow the at least one targeting agent to be incorporated in the polymer shell and/or attached to a surface of the polymer shell to form the nanobubble composition.
A method, comprising the step of:
- (1) administering an effective amount of at least one ultrasound responsive targeted nanobubble composition to a patient in need thereof, wherein the nanobubble composition comprises a hollow core containing at least one gas, a polymer shell encircling the hollow core, at least one therapeutic agent disposed in the hollow core and/or encapsulated within the polymer shell, and at least one targeting agent incorporated in the polymer shell and/or attached to a surface of the polymer shell, wherein the at least one targeting agent targets the nanobubble composition to at least a portion of a musculoskeletal system of the patient.
Dependencies are inferred from the claim text.